Fluidigm

About Fluidigm

Fluidigm is a pioneering biotechnology company that focuses on developing innovative solutions for life sciences research and clinical applications. Established with the vision of transforming the way scientists conduct experiments, Fluidigm has become a leader in the field of microfluidics and genomics.

The company specializes in providing advanced technologies that enable researchers to perform high-throughput analysis of biological samples. Their flagship products include integrated fluidic circuits and mass cytometry systems, which allow for unprecedented levels of data acquisition and analysis.

Fluidigm’s commitment to innovation is evident in their continuous investment in research and development. They strive to enhance the capabilities of their platforms, making them more accessible and user-friendly for researchers worldwide.

With a strong emphasis on collaboration, Fluidigm partners with academic institutions, pharmaceutical companies, and healthcare providers to drive advancements in precision medicine and personalized therapies. Their solutions are designed to facilitate breakthroughs in areas such as cancer research, immunology, and genetic disorders.

Fluidigm is headquartered in the UK, where it operates with a dedicated team of experts who are passionate about advancing scientific discovery. The company is committed to sustainability and ethical practices, ensuring that their operations have a positive impact on society and the environment.

As Fluidigm continues to grow, they remain focused on their mission to empower researchers with cutting-edge tools that accelerate the pace of scientific discovery and improve patient outcomes.